Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,607
  • Shares Outstanding, K 28,056
  • Annual Sales, $ 0 K
  • Annual Income, $ -33,770 K
  • 60-Month Beta 1.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.84
Trade LIFE with:

Options Overview Details

View History
  • Implied Volatility 120.16% ( -78.82%)
  • Historical Volatility 59.34%
  • IV Percentile 71%
  • IV Rank 18.14%
  • IV High 303.99% on 05/11/22
  • IV Low 79.43% on 06/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 3.10
  • Today's Open Interest 2,463
  • Open Int (30-Day) 3,875

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.44
  • Number of Estimates 4
  • High Estimate -0.36
  • Low Estimate -0.48
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.68 +4.48%
on 05/24/22
4.41 -36.51%
on 04/26/22
-1.56 (-35.78%)
since 04/25/22
3-Month
2.68 +4.48%
on 05/24/22
6.62 -57.70%
on 03/23/22
-2.25 (-44.55%)
since 02/25/22
52-Week
2.68 +4.48%
on 05/24/22
13.10 -78.63%
on 09/23/21
-1.46 (-34.27%)
since 05/25/21

Most Recent Stories

More News
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 13, 2022 (GLOBE NEWSWIRE) --  aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of...

LIFE : 2.80 (-0.36%)
Love Hemp Group PLC Announces Update to Announcement of 9 May 2022

LONDON, UK / ACCESSWIRE / May 13, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focused on CBD health and wellness solutions, provides a further update at the...

WRHLF : 0.0030 (+50.00%)
LIFE : 2.80 (-0.36%)
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates

Atyr Pharma (LIFE) delivered earnings and revenue surprises of -29.41% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LIFE : 2.80 (-0.36%)
ITCI : 56.67 (-0.51%)
Love Hemp Group PLC Announces Update Regarding Trading Suspension

LONDON, UK / ACCESSWIRE / May 9, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, wishes to provide an update on...

WRHLF : 0.0030 (+50.00%)
LIFE : 2.80 (-0.36%)
Love Hemp Group PLC Announces Update Regarding Suspension & Feb 2022 Fundraise

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

WRHLF : 0.0030 (+50.00%)
LIFE : 2.80 (-0.36%)
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results

Management to host conference call and webcast on May 9th at 5:00 pm EDT / 2:00 pm PDT...

LIFE : 2.80 (-0.36%)
aTyr Pharma (LIFE) Up on Orphan Drug Status for Efzofitimod

The FDA bestows an Orphan Drug status to aTyr Pharma's (LIFE) lead candidate, efzofitimod, for the treatment of systemic sclerosis. Shares rise.

LIFE : 2.80 (-0.36%)
VYGR : 5.96 (-1.49%)
APLT : 1.4800 (+0.68%)
ALGS : 1.1900 (+3.48%)
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis

Second U.S. orphan drug designation for efzofitimod clinical program...

LIFE : 2.80 (-0.36%)
aTyr Pharma Presents Preclinical Research Characterizing Effects of ATYR2810 in Highly Aggressive Tumor Subtypes at the 2022 AACR Annual Meeting

Findings suggest that ATYR2810 reduces metastasis and enhances chemosensitivity by downregulating key genes linked to these processes....

LIFE : 2.80 (-0.36%)
Does Atyr Pharma (LIFE) Have the Potential to Rally 236% as Wall Street Analysts Expect?

The consensus price target hints at a 235.8% upside potential for Atyr Pharma (LIFE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

LIFE : 2.80 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 2.96
2nd Resistance Point 2.91
1st Resistance Point 2.86
Last Price 2.80
1st Support Level 2.76
2nd Support Level 2.71
3rd Support Level 2.66

See More

52-Week High 13.10
Fibonacci 61.8% 9.12
Fibonacci 50% 7.89
Fibonacci 38.2% 6.66
Last Price 2.80
52-Week Low 2.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar